About

I am an award-winning writer, editor, photographer and designer with more than 30 years of experience in the media. After studying at the University of Leeds, then London and Anglia HEC, I moved to Canada in the 1980s and started out on the radio while also writing for various music and sports publications, and doing freelance photography. I then edited some magazines before working at a science organization, doing communications and editing publications in a programming language called LaTeX that was challenging but exciting.

Following that, I edited a newspaper, spent some time in the US, and then moved back to the UK where I edited a food B2B publication.
I’ve written, and taken photographs for, hundreds of publications around the world, as well as for books, album covers, DVDs, and shot coverage for documentaries. I’ve edited books, written nine of my own, and done redesigns for several publications. And now I’m writing about biotech, as well as creating videos and a weekly podcast.

I’ve done other things, like running an aquarium, teaching photography and drumming (not at the same time), and running football (soccer) refereeing courses.

In what spare time I have, I love spending time with my wife, son and dog, challenging hikes up the Scottish hills (and down again), playing and writing music, watching baseball and soccer, and collecting memorabilia and autographs.

Articles by Jim Cornall

More News! 25 Apr 2023

More efficient and cost-effective mRNA vaccines developed

LifeArc launches £40M funding call to create Translational Rare Disease Centres 

RNA-based nanodrugs cause cancer cells to collapse – 80% survival rate for ovarian cancer in lab models

Life Biosciences gene therapy data shows visual function restored in primates

New discovery “an area of cancer research with tremendous promise for breakthroughs”

Podcast 21 Apr 2023

Beyond Biotech podcast 42

ADVERTISEMENT

RetinAI and Boehringer Ingelheim to use AI to develop treatment for geographic atrophy

Orphalan announces U.S. launch of drug to treat Wilson disease

Can artificial intelligence predict future pandemics?

FDA approves Genentech’s lymphoma drug

Hasten raises $315M for acquisitions and pipeline development

Wound treatment boost from new color-changing dressing

ADVERTISEMENT